Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Neurology
    August 2022
  1. AKINCI M, Pena-Gomez C, Operto G, Fuentes-Julian S, et al
    Pre-pandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults.
    Neurology. 2022 Aug 2. pii: WNL.0000000000200948.
    >> Share

  2. CEDRES N, Ferreira D, Nemy M, Machado A, et al
    Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals.
    Neurology. 2022 Aug 2. pii: WNL.0000000000200930.
    >> Share

    July 2022
  3. SHAHIM P, Zetterberg H, Simren J, Ashton NJ, et al
    Association of Plasma Biomarker Levels With Their CSF Concentration and the Number and Severity of Concussions in Professional Athletes.
    Neurology. 2022;99:e347-e354.
    >> Share

  4. SCHINDLER SE, Karikari TK, Ashton NJ, Henson RL, et al
    Effect of Race on Prediction of Brain Amyloidosis by Plasma Abeta42/Abeta40, Phosphorylated Tau, and Neurofilament Light.
    Neurology. 2022;99:e245-e257.
    >> Share

  5. BORLAND E, Edgar C, Stomrud E, Cullen N, et al
    Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials.
    Neurology. 2022 Jul 14. pii: WNL.0000000000200817.
    >> Share

  6. WYNN M
    My First Patient With Alzheimer's.
    Neurology. 2022 Jul 14. pii: WNL.0000000000201087.
    >> Share

  7. KEUSS SE, Coath W, Nicholas JM, Poole T, et al
    Associations of beta-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort.
    Neurology. 2022;99:e129-e141.
    >> Share

    June 2022
  8. MONTINE TJ, Corrada MM, Kawas C, Bukhari S, et al
    Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest-Old.
    Neurology. 2022 Jun 15. pii: WNL.0000000000200832.
    >> Share

  9. PETERSEN KK, Lipton RB, Grober E, Davatzikos C, et al
    Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data.
    Neurology. 2022;98:e2425-e2435.
    >> Share

  10. YANG JJ, Keohane LM, Pan X, Qu R, et al
    Association of Healthy Lifestyles with Risk of Alzheimer Disease and Related Dementias in Low-Income Black and White Americans.
    Neurology. 2022 Jun 13. pii: WNL.0000000000200774.
    >> Share

  11. TANG B, Wang Y, Jiang X, Thambisetty M, et al
    Genetic Variation in Targets of Anti-diabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study.
    Neurology. 2022 Jun 2. pii: WNL.0000000000200771.
    >> Share

    May 2022
  12. KUMAR A, Janelidze S, Stomrud E, Palmqvist S, et al
    beta-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease.
    Neurology. 2022 May 31. pii: WNL.0000000000200605.
    >> Share

  13. DUMURGIER J, Sabia S, Zetterberg H, Teunissen C, et al
    Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
    Neurology. 2022 May 26. pii: WNL.0000000000200735.
    >> Share

  14. MOHANTY R, Ferreira D, Frerich S, Muehlboeck JS, et al
    Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Neurology. 2022 May 24. pii: WNL.0000000000200573.
    >> Share

  15. MCGIRR A, Nathan S, Ghahremani M, Gill S, et al
    Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms.
    Neurology. 2022;98:e2132-e2139.
    >> Share

  16. XICOTA L, Gyorgy B, Grenier-Boley B, Lecoeur A, et al
    Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults.
    Neurology. 2022 May 23. pii: WNL.0000000000200544.
    >> Share

  17. FARNSWORTH VON CEDERWALD B, Josefsson M, Wahlin A, Nyberg L, et al
    Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia.
    Neurology. 2022;98:e2013-e2022.
    >> Share

  18. LI Z, Heckman MG, Kanekiyo T, Martens YA, et al
    Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment.
    Neurology. 2022;98:e2036-e2045.
    >> Share

  19. ASKEN BM, Tanner JA, VandeVrede L, Mantyh WG, et al
    Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology.
    Neurology. 2022 May 16. pii: WNL.0000000000200678.
    >> Share

  20. AGOSTA F, Filippi M
    Natural Speech Analysis: A Window Into Alzheimer Disease Phenotypes.
    Neurology. 2022 May 4. pii: WNL.0000000000200843.
    >> Share

  21. BEYDOUN MA, Beydoun HA, Fanelli-Kuczmarski MT, Weiss J, et al
    Association of Serum Antioxidant Vitamins and Carotenoids With Incident Alzheimer Disease and All-Cause Dementia Among US Adults.
    Neurology. 2022 May 4. pii: WNL.0000000000200289.
    >> Share

    April 2022
  22. CHO S, Quilico Cousins KA, Shellikeri S, Ash S, et al
    Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology.
    Neurology. 2022 Apr 29. pii: WNL.0000000000200581.
    >> Share

  23. WHITWELL J, Martin PR, Graff-Radford J, Machulda M, et al
    Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200336.
    >> Share

  24. VOGEL JW, Tosun D
    Multiple Cortical to Striatal Accumulation Trajectories of beta-Amyloid: Do All Roads Lead to Rome?
    Neurology. 2022;98:695-696.
    >> Share

  25. COLLIJ LE, Salvado G, Wottschel V, Mastenbroek SE, et al
    Spatial-Temporal Patterns of beta-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis.
    Neurology. 2022;98:e1692-e1703.
    >> Share

  26. BEAUDIN AE, McCreary CR, Mazerolle EL, Gee M, et al
    Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy.
    Neurology. 2022;98:e1716-e1728.
    >> Share

  27. ARANHA MR, Fortea J, Carmona-Iragui M
    Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease.
    Neurology. 2022 Apr 25. pii: WNL.0000000000200704.
    >> Share

  28. FRANK B, Ally M, Tripodis Y, Puzo C, et al
    Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease.
    Neurology. 2022 Apr 20. pii: WNL.0000000000200304.
    >> Share

  29. BEAMAN C, Kozii K, Hilal S, Liu M, et al
    Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration.
    Neurology. 2022;98:e1605-e1616.
    >> Share

  30. DIFRANCESCO JC, Stanzani L
    Increased Brain Volume: A Novel Biomarker of Neurodegeneration?
    Neurology. 2022;98:649-650.
    >> Share

  31. SIBLE IJ, Nation DA
    Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200302.
    >> Share

  32. GRAFF-RADFORD J, Josephs K
    Author Response: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2022;98:644.
    >> Share

  33. DASHEIFF R
    Reader Response: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2022;98:643.
    >> Share

  34. SIEGLER JE 3RD, Galetta S
    Editors' Note: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2022;98:643.
    >> Share

  35. FARRELL ME, Papp KV, Buckley RF, Jacobs HIL, et al
    Association of Emerging beta-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Neurology. 2022;98:e1512-e1524.
    >> Share

  36. TIDEMAN P, Stomrud E, Leuzy A, Mattsson-Carlgren N, et al
    Association of beta-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
    Neurology. 2022;98:e1525-e1533.
    >> Share

  37. GAUTHREAUX KM, Teylan MA, Katsumata Y, Mock C, et al
    Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
    Neurology. 2022;98:e1422-e1433.
    >> Share

  38. GU Y, Kociolek A, Fernandez KK, Cosentino SA, et al
    Clinical Trajectories at the End of Life in Dementia Patients With Alzheimer Disease and Lewy Body Neuropathologic Changes.
    Neurology. 2022 Apr 4. pii: WNL.0000000000200259.
    >> Share

    March 2022
  39. GUAN Y, Ebrahimzadeh SA, Cheng CH, Chen W, et al
    Association of Diabetes and Hypertension With Brain Structural Integrity and Cognition in the Boston Puerto Rican Health Study Cohort.
    Neurology. 2022 Mar 30. pii: WNL.0000000000200120.
    >> Share

  40. ZAMMIT AR, Yu L, Petyuk V, Schneider JA, et al
    Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults.
    Neurology. 2022;98:e1304-e1314.
    >> Share

  41. SALINAS J, Beiser AS, Samra JK, O'Donnell A, et al
    Association of Loneliness With 10-Year Dementia Risk and Early Markers of Vulnerability for Neurocognitive Decline.
    Neurology. 2022;98:e1337-e1348.
    >> Share

  42. PETERSEN RC
    Detecting Alzheimer Disease Clinically: How Early Can We Go?
    Neurology. 2022 Mar 25. pii: WNL.0000000000200172.
    >> Share

  43. VAN DE BEEK M, Ooms FAH, Ebenau JL, Barkhof F, et al
    Association of the ATN Research Framework With Clinical Profile, Cognitive Decline, and Mortality in Patients With Dementia With Lewy Bodies.
    Neurology. 2022;98:e1262-e1272.
    >> Share

  44. VAN LOENHOUD AC, Groot C, Bocancea DI, Barkhof F, et al
    Association of Education and Intracranial Volume With Cognitive Trajectories and Mortality Rates Across the Alzheimer Disease Continuum.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200116.
    >> Share

  45. JOSEPHS KA, Weigand SD, Whitwell J
    Characterizing Amyloid Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200287.
    >> Share

  46. HESHMATOLLAH A, Fani L, Koudstaal PJ, Ghanbari M, et al
    Plasma Amyloid Beta, Total-Tau and Neurofilament Light Chain Levels and the Risk of Stroke: A Prospective Population-Based Study.
    Neurology. 2022 Mar 1. pii: WNL.0000000000200004.
    >> Share

    February 2022
  47. DAY GS, Scarmeas N, Dubinsky R, Coerver K, et al
    Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: Report of the AAN Guidelines Subcommittee.
    Neurology. 2022 Feb 23. pii: WNL.0000000000200176.
    >> Share

  48. GROBER E, Lipton RB, Sperling RA, Papp KV, et al
    Associations of Stages of Objective Memory Impairment (SOMI) with Amyloid PET and Structural MRI: The A4 Study.
    Neurology. 2022 Feb 23. pii: WNL.0000000000200046.
    >> Share

  49. MATTSSON-CARLGREN N, Grinberg LT, Boxer A, Ossenkoppele R, et al
    Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Neurology. 2022 Feb 16. pii: WNL.0000000000200040.
    >> Share

  50. CHU WT, Wang WE, Zaborszky L, Golde TE, et al
    Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract.
    Neurology. 2022;98:e700-e710.
    >> Share

  51. EBENAU JL, Pelkmans W, Verberk IMW, Verfaillie S, et al
    Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
    Neurology. 2022 Feb 2. pii: WNL.0000000000200035.
    >> Share

    January 2022
  52. BOWN CW, Carare RO, Schrag MS, Jefferson AL, et al
    Physiology and Clinical Relevance of Enlarged Perivascular Spaces in the Aging Brain.
    Neurology. 2022;98:107-117.
    >> Share

  53. WHITTINGTON MD, Campbell JD, Rind D, Fluetsch N, et al
    Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease.
    Neurology. 2022 Jan 12. pii: WNL.0000000000013314.
    >> Share

  54. BALLARINI T, Melo van Lent D, Wagner M
    Author Response: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age.
    Neurology. 2022;98:89-90.
    >> Share

  55. GANESH A, Galetta S
    Editors' Note: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age.
    Neurology. 2022;98:88.
    >> Share

  56. BRENNER SR
    Reader Response: Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age.
    Neurology. 2022;98:88-89.
    >> Share

  57. DA SILVA SOYOMBO NK, Rocha EL, Xavier LB, Oliveira RA, et al
    Biomarkers for Differential Diagnosis Between Chronic Traumatic Encephalopathy and Alzheimer Disease: A Systematic Review.
    Neurology. 2022;98.
    >> Share

    December 2021
  58. YOO HS, Jeon S, Cavedo E, Ko M, et al
    Association of beta-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.
    Neurology. 2021 Dec 30. pii: WNL.0000000000013277.
    >> Share

  59. CULLEN N, Janelidze S, Palmqvist S, Stomrud E, et al
    Association of CSF Abeta38 Levels With Risk of Alzheimer Disease-Related Decline.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013228.
    >> Share

  60. YU L, Boyle PA, Wingo AP, Yang J, et al
    Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013252.
    >> Share

  61. LI Y, Schindler SE, Bollinger JG, Ovod V, et al
    Validation of Plasma Amyloid-beta 42/40 for Detecting Alzheimer Disease Amyloid Plaques.
    Neurology. 2021 Dec 14. pii: WNL.0000000000013211.
    >> Share

    November 2021
  62. SMIRNOV DS, Salmon DP, Galasko D, Goodwill VS, et al
    Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.
    Neurology. 2021 Nov 22. pii: WNL.0000000000013107.
    >> Share

  63. ACOSTA LM
    I Wasn't There: Caring for a Patient With Trisomy 21, Alzheimer Disease, and Epilepsy Until His Final Days With COVID-19.
    Neurology. 2021 Nov 22. pii: WNL.0000000000013109.
    >> Share

  64. CHIONG W, Tolchin BD, Bonnie RJ, Busl K, et al
    Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.
    Neurology. 2021 Nov 17. pii: WNL.0000000000013053.
    >> Share

  65. KUSCHPEL MS
    Reader Response: Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Neurology. 2021;97:964-965.
    >> Share

  66. SCHELBAUM E, Loughlin L, Jett S, Zang C, et al
    Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife.
    Neurology. 2021 Nov 3. pii: WNL.0000000000012941.
    >> Share

    October 2021
  67. LEUZY A, Janelidze S, Mattsson-Carlgren N, Palmqvist S, et al
    Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.
    Neurology. 2021;97:e1681-e1694.
    >> Share

    September 2021
  68. KIM YJ, Karceski S
    Alzheimer Disease and Mood.
    Neurology. 2021;97:e1363-e1366.
    >> Share

  69. EDMONDS EC, Smirnov DS, Thomas KR, Graves LV, et al
    Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes.
    Neurology. 2021;97:e1288-e1299.
    >> Share

  70. MILA-ALOMA M, Brinkmalm A, Ashton NJ, Kvartsberg H, et al
    CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012853.
    >> Share

  71. GARNIER-CRUSSARD A, Krolak-Salmon P
    Reader Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;97:608.
    >> Share

  72. THERRIAULT J, Pascoal T, Gauthier S, Rosa-Neto P, et al
    Author Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;97:609.
    >> Share

  73. JEONG SH, Kim HR, Kim J, Kim H, et al
    Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment.
    Neurology. 2021;97:e1110-e1122.
    >> Share

  74. HERSHEY LA, Tarawneh R
    Clinical Efficacy, Drug Safety, and Surrogate Endpoints: Has Aducanumab Met All of Its Expectations?
    Neurology. 2021;97:517-518.
    >> Share

  75. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    >> Share

  76. BUCIUC M, Josephs KA, Jones DT, Whitwell JL, et al
    Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012783.
    >> Share

  77. MCCARTER S, Lesnick TG, Lowe V, Mielke MM, et al
    Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-beta PET Signal.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012770.
    >> Share

    August 2021
  78. FRISON E, Proust-Lima C, Mangin JF, Habert MO, et al
    Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
    Neurology. 2021;97:e836-e848.
    >> Share

  79. SANDERS AE
    A Century-Old Problem: Cognition and Neuropsychiatric Symptoms in Alzheimer Disease.
    Neurology. 2021 Aug 20. pii: WNL.0000000000012616.
    >> Share

  80. EIKELBOOM WS, van den Berg E, Singleton EH, Baart SJ, et al
    Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Neurology. 2021 Aug 19. pii: WNL.0000000000012598.
    >> Share

  81. LI J
    Alzheimer's Villanelle.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012612.
    >> Share

  82. PETERSEN RC
    Mild Cognitive Impairment Criteria in Alzheimer's Disease Neuroimaging Initiative: Meeting Biological Expectations.
    Neurology. 2021 Aug 2. pii: WNL.0000000000012588.
    >> Share

    July 2021
  83. TAO Q, Alvin Ang TF, Akhter-Khan SC, Itchapurapu IS, et al
    Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous Apolipoprotein E varepsilon4 Carriers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012512.
    >> Share

  84. BOCANCEA DI, Catharina van Loenhoud A, Groot C, Barkhof F, et al
    Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods: A Systematic Review and Meta-analysis.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012499.
    >> Share

  85. GROTHE MJ, Moscoso A, Ashton NJ, Karikari TK, et al
    Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012513.
    >> Share

  86. POGGESI A
    Resilience and Resistance in Aging and Alzheimer Disease: Another Step to Fill the Gap Between Clinicians and Researchers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012500.
    >> Share

  87. WILSON RS, Wang T, Yu L, Grodstein F, et al
    Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia.
    Neurology. 2021 Jul 14. pii: WNL.0000000000012388.
    >> Share

  88. SALLOWAY S, Cummings J
    Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease.
    Neurology. 2021 Jul 7. pii: WNL.0000000000012451.
    >> Share

    June 2021
  89. BUCIUC M, Duffy JR, Machulda MM, Graff-Radford J, et al
    Clinical, Imaging, and Pathologic Characteristics of Patients With Right Versus Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012322.
    >> Share

  90. JUTTEN RJ, Sikkes SAM, Van der Flier WM, Scheltens P, et al
    Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity.
    Neurology. 2021;96:e2673-e2684.
    >> Share

  91. BUCKLEY RF, Knopman DS
    Cognitive Heterogeneity in Alzheimer Clinical Trials: Harnessing Noise to Achieve Meaningfulness.
    Neurology. 2021;96:1017-1018.
    >> Share

    May 2021
  92. HUGHES TM, Hajjar I
    Is Late-onset Alzheimer Disease Spelled "ATV(N)"?
    Neurology. 2021 May 24. pii: WNL.0000000000012259.
    >> Share

  93. DONADIO V, Wang Z, Incensi A, Rizzo G, et al
    In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
    Neurology. 2021;96:e2513-e2524.
    >> Share

  94. FRIEDMAN LG, McKeehan N, Hara Y, Cummings JL, et al
    Value-Generating Exploratory Trials in Neurodegenerative Dementias.
    Neurology. 2021;96:944-954.
    >> Share

  95. MAYBLYUM DV, Becker JA, Jacobs HIL, Buckley RF, et al
    Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.
    Neurology. 2021 May 5. pii: WNL.0000000000012108.
    >> Share

  96. BALLARINI T, Melo van Lent D, Brunner J, Schroder A, et al
    Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age.
    Neurology. 2021 May 5. pii: WNL.0000000000012067.
    >> Share

  97. BELLAVER B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, et al
    Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021 May 5. pii: WNL.0000000000012109.
    >> Share

  98. HAZRATI LN, Schwab N
    Embracing the Unknown in the Diagnosis of Traumatic Encephalopathy Syndrome.
    Neurology. 2021;96:835-836.
    >> Share

    April 2021
  99. BOERWINKLE AH, Wisch JK, Chen CD, Gordon BA, et al
    Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012123.
    >> Share

  100. KARCESKI S
    The Effects of Long-term Medication Use in Alzheimer Disease.
    Neurology. 2021;96:e2247-e2250.
    >> Share

  101. XU H, Garcia-Ptacek S, Jonsson L, Wimo A, et al
    Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Neurology. 2021;96:e2220-e2230.
    >> Share

  102. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
    Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
    >> Share

  103. HAMILTON CA, Matthews FE, Donaghy PC, Taylor JP, et al
    Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease.
    Neurology. 2021 Apr 19. pii: WNL.0000000000012024.
    >> Share

  104. HOWARD E, Irwin DJ, Rascovsky K, Nevler N, et al
    Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
    Neurology. 2021;96:e1855-e1864.
    >> Share

    March 2021
  105. QIAN J, Betensky RA, Hyman BT, Serrano-Pozo A, et al
    Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.
    Neurology. 2021 Mar 26. pii: WNL.0000000000011883.
    >> Share

  106. GOTTESMAN RF, Hamilton R
    Recruiting Diverse Populations in Clinical Trials: How Do We Overcome Selection Bias?
    Neurology. 2021;96:509-510.
    >> Share

  107. KANG SH, Kim ME, Jang H, Kwon H, et al
    Amyloid Positivity in Alzheimer/Subcortical-Vascular Spectrum.
    Neurology. 2021 Mar 15. pii: WNL.0000000000011833.
    >> Share

  108. SMIRNOV DS, Galasko D, Hiniker A, Edland S, et al
    Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease.
    Neurology. 2021 Mar 15. pii: WNL.0000000000011772.
    >> Share

  109. BARKHOF BF, Pressman PS
    Time Is of the Essence: Early Detection of Incipient Alzheimer Pathology.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011739.
    >> Share

    February 2021
  110. ROBINSON-PAPP J, Saylor D
    HIV in the Brain: From Devastating Dementia to White Matter Hyperintensities.
    Neurology. 2021 Feb 26. pii: WNL.0000000000011735.
    >> Share

  111. HUYNH K, Piguet O, Kwok J, Dobson-Stone C, et al
    Clinical and Biological Correlates of White Matter Hyperintensities in Patients with Behavioral-variant Frontotemporal Dementia and Alzheimer Disease.
    Neurology. 2021 Feb 17. pii: WNL.0000000000011638.
    >> Share

  112. THERRIAULT J, Pascoal TA, Benedet AL, Tissot C, et al
    Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;96:e975-e985.
    >> Share

  113. RENTZ DM, Papp KV, Mayblyum DV, Sanchez JS, et al
    Association of Digital Clock Drawing with PET Amyloid and Tau Pathology in Normal Older Adults.
    Neurology. 2021 Feb 15. pii: WNL.0000000000011697.
    >> Share

  114. DETERS K, Napolioni V, Sperling RA, Greicius MD, et al
    Amyloid PET imaging in self-identified non-Hispanic Blacks from the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011599.
    >> Share

  115. FERREIRA D, Nordberg A, Westman E
    Author Response: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:238.
    >> Share

  116. ULEMAN JF, Melis RJF, Olde Rikkert MGM
    Reader Response: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:237-238.
    >> Share

  117. GANESH A, Galetta S
    Editors' Note: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:237.
    >> Share

    January 2021
  118. JOSEPH-MATHURIN N, Wang G, Kantarci K, Jack CR Jr, et al
    Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease.
    Neurology. 2021 Jan 25. pii: WNL.0000000000011542.
    >> Share

  119. SAJJADI SA, Ash S, Cappa S
    Glass half full: Preservation of memory in Alzheimer-related primary progressive aphasia.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011404.
    >> Share

  120. MESULAM MM, Coventry C, Kuang A, Bigio EH, et al
    Memory resilience in Alzheimer's disease with primary progressive aphasia.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011397.
    >> Share

  121. BLAZHENETS G, Frings L, Ma Y, Sorensen A, et al
    Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011521.
    >> Share

  122. JAGUST WJ, Landau SM
    Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011524.
    >> Share

  123. TRELLE AN, Carr VA, Wilson EN, Swarovski MS, et al
    Association of CSF Biomarkers with Hippocampal-dependent Memory in Preclinical Alzheimer Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011477.
    >> Share

  124. THERRIAULT J, Pascoal TA, Savard M, Benedet AL, et al
    Topographic Distribution of Amyloid-beta, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease.
    Neurology. 2021;96:e81-e92.
    >> Share

    December 2020
  125. KNOPMAN DS, Jagust WJ
    Alzheimer Disease Spectrum: Syndrome and Etiology from Clinical and PET Imaging Perspectives.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011415.
    >> Share

  126. KOYAMA AK, Irwin DJ
    Alzheimer disease biomarker profiles in dementia with Lewy bodies: Does A plus T spell D-L-B?
    Neurology. 2020;95:1076-1077.
    >> Share

  127. GICAS KM, Honer WG, Wilson RS, Boyle PA, et al
    Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes.
    Neurology. 2020;95:e3303-e3312.
    >> Share

  128. PETTIGREW C, Soldan A, Wang J, Wang MC, et al
    Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline.
    Neurology. 2020;95:e3093-e3103.
    >> Share

  129. PALMQVIST S, Eshaghi A
    Spatial distribution of tau and beta-amyloid pathologies and their role in different Alzheimer's disease phenotypes.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011272.
    >> Share

  130. LA JOIE R, Visani AV, Lesman-Segev OH, Baker SL, et al
    Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011270.
    >> Share

    November 2020
  131. KARCESKI S
    How a buildup of abnormal proteins in the brain may be the key to understanding Alzheimer disease.
    Neurology. 2020;95:e2951-e2953.
    >> Share

  132. YOUNAN D, Wang X, Casanova R, Barnard R, et al
    PM2.5 associated with gray matter atrophy reflecting increased Alzheimers risk in older women.
    Neurology. 2020 Nov 18. pii: WNL.0000000000011149.
    >> Share

  133. ILLAN-GALA I, Lleo A, Karydas A, Staffaroni AM, et al
    Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease.
    Neurology. 2020 Nov 16. pii: WNL.0000000000011226.
    >> Share

  134. GRAFF-RADFORD J, Knopman D, Jones D
    Author response: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:846.
    >> Share

  135. ALLALI G, Laticevschi T
    Reader response: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:845-846.
    >> Share

  136. SIEGLER JE 3RD, Galetta S
    Editors' note: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:845.
    >> Share

    October 2020
  137. KIM HR, Lee T, Choi JK, Jeong Y, et al
    Genetic variants beyond amyloid and tau associated with cognitive decline: A cohort study.
    Neurology. 2020;95:e2366-e2377.
    >> Share

  138. WEIGAND AJ, Bondi MW, Thomas KR, Campbell NL, et al
    Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.
    Neurology. 2020;95:e2295-e2304.
    >> Share

  139. KERCHNER GA, Filippi M
    Abeta-PET pathology accumulation index: Ready for the clinic?
    Neurology. 2020 Oct 19. pii: WNL.0000000000011060.
    >> Share

  140. LEUZY A, Lilja J, Buckley CJ, Ossenkoppele R, et al
    Derivation and utility of an Abeta-PET pathology accumulation index to estimate Abeta load.
    Neurology. 2020 Oct 19. pii: WNL.0000000000011031.
    >> Share

  141. BENNETT DA, Knopman DS
    Extending Alzheimer disease biomarker studies into the Hispanic community.
    Neurology. 2020;95:665-666.
    >> Share

  142. NAG S, Barnes LL, Yu L, Wilson RS, et al
    Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents.
    Neurology. 2020;95:e2056-e2064.
    >> Share

  143. GERTJE EC, van Westen D, Panizo C, Mattsson-Carlgren N, et al
    Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011046.
    >> Share

  144. KAPASI A, Yu L, Boyle PA, Barnes LL, et al
    Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging.
    Neurology. 2020;95:e1951-e1962.
    >> Share

  145. CATRICALA E, Polito C, Presotto L, Esposito V, et al
    Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010967.
    >> Share

    September 2020
  146. HANES J, Kovac A, Kvartsberg H, Kontsekova E, et al
    Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias.
    Neurology. 2020 Sep 24. pii: WNL.0000000000010814.
    >> Share

  147. BRENOWITZ WD, Besser LM, Kukull WA, Keene CD, et al
    Clinician-judged hearing impairment and associations with neuropathologic burden.
    Neurology. 2020;95:e1640-e1649.
    >> Share

  148. SAN LEE J, Lee H, Park S, Choe Y, et al
    Association between APOE epsilon2 and Abeta burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment.
    Neurology. 2020 Sep 14. pii: WNL.0000000000010811.
    >> Share

  149. CIRRITO JR, Wallace CE, Yan P, Davis TA, et al
    Effect of Escitalopram on Abeta levels and plaque load in an Alzheimer mouse model.
    Neurology. 2020 Sep 10. pii: WNL.0000000000010733.
    >> Share

  150. SCHREIBER S, DiFrancesco JC
    Impaired occipital cerebrovascular reactivity as a biomarker for vascular beta-amyloid.
    Neurology. 2020;95:415-416.
    >> Share

  151. GUZMAN-VELEZ E, Martinez J, Papp K, Baena A, et al
    Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.
    Neurology. 2020;95:e1312-e1321.
    >> Share

  152. BRENOWITZ WD, Filshtein TJ, Yaffe K, Walter S, et al
    Association of genetic risk for Alzheimer disease and hearing impairment.
    Neurology. 2020 Sep 2. pii: WNL.0000000000010709.
    >> Share

  153. LUO J, Agboola F, Grant E, Masters CL, et al
    Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
    Neurology. 2020 Sep 1. pii: WNL.0000000000010747.
    >> Share

    August 2020
  154. HUANG J, Zuber V, Matthews PM, Elliott P, et al
    Sleep, major depressive disorder and Alzheimer's disease: A Mendelian randomisation study.
    Neurology. 2020 Aug 19. pii: WNL.0000000000010463.
    >> Share

  155. KIM JW, Byun MS, Lee JH, Yi D, et al
    Serum albumin and beta-amyloid deposition in the human brain.
    Neurology. 2020;95:e815-e826.
    >> Share

  156. MOFRAD RB, Tijms BM, Scheltens P, Barkhof F, et al
    Sex differences in CSF biomarkers vary by Alzheimer's disease stage and APOE epsilon4 genotype.
    Neurology. 2020 Aug 11. pii: WNL.0000000000010629.
    >> Share

  157. VAN DER ZANDE JJ, Gouw AA, van Steenoven I, van de Beek M, et al
    Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
    Neurology. 2020;95:e662-e670.
    >> Share

  158. LAM AD, Sarkis RA, Pellerin KR, Jing J, et al
    Association of epileptiform abnormalities and seizures in Alzheimer disease.
    Neurology. 2020 Aug 6. pii: WNL.0000000000010612.
    >> Share

  159. GONNEAUD J, Bedetti C, Binette AP, Benzinger TLS, et al
    Association of education with Abeta burden in preclinicial familial and sporadic Alzheimer disease.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010314.
    >> Share

    July 2020
  160. ARENAZA-URQUIJO EM EM, Salvado G, Operto G, Minguillon C, et al
    Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer's biomarkers.
    Neurology. 2020 Jul 31. pii: WNL.0000000000010527.
    >> Share

  161. BAUMEISTER SE, Karch A, Bahls M, Teumer A, et al
    Physical activity and risk of Alzheimer's disease: a two-sample Mendelian randomization study.
    Neurology. 2020 Jul 17. pii: WNL.0000000000010013.
    >> Share

  162. COLLIJ LE, Heeman F, Salvado G, Ingala S, et al
    Multi-tracer model for staging cortical amyloid deposition using PET imaging.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010256.
    >> Share

  163. SAIF N, Niotis K, Dominguez M, Hodes JF, et al
    Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial.
    Neurology. 2020 Jul 14. pii: WNL.0000000000009859.
    >> Share

  164. SUR S, Lin Z, Li Y, Yasar S, et al
    Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance.
    Neurology. 2020 Jul 13. pii: WNL.0000000000010133.
    >> Share

  165. SWITZER AR, Cheema I, McCreary CR, Zwiers A, et al
    Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment.
    Neurology. 2020 Jul 8. pii: WNL.0000000000010201.
    >> Share

  166. EBENAU JL, Timmers T, Wesselman LMP, Verberk IMW, et al
    ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project.
    Neurology. 2020;95:e46-e58.
    >> Share

  167. SAKAE N, Santos OA, Pedraza O, Litvan I, et al
    Clinical and pathologic features of cognitive-predominant corticobasal degeneration.
    Neurology. 2020;95:e35-e45.
    >> Share

  168. TEIPEL SJ, Fritz HC, Grothe MJ
    Neuropathological features associated with basal forebrain atrophy in Alzheimer's disease.
    Neurology. 2020 Jul 6. pii: WNL.0000000000010192.
    >> Share

  169. WOLTERS FJ, Chibnik LB, Waziry R, Anderson R, et al
    27-year time trends in dementia incidence in Europe and the US: the Alzheimer Cohorts Consortium.
    Neurology. 2020 Jul 1. pii: WNL.0000000000010022.
    >> Share

    June 2020
  170. TIBLE M, Sandelius A, Hoglund K, Brinkmalm A, et al
    Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease.
    Neurology. 2020 Jun 25. pii: WNL.0000000000010131.
    >> Share

  171. RAHMAN A, Schelbaum E, Hoffman K, Diaz I, et al
    Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
    Neurology. 2020 Jun 24. pii: WNL.0000000000009781.
    >> Share

  172. DHANA K, Evans DA, Rajan KB, Bennett DA, et al
    Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies.
    Neurology. 2020 Jun 17. pii: WNL.0000000000009816.
    >> Share

  173. BUCIUC M, Botha H, Murray ME, Schwarz CG, et al
    Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
    Neurology. 2020 Jun 9. pii: WNL.0000000000009722.
    >> Share

  174. QIN L, Zhu X, Friedland RP
    ApoE and mitochondrial dysfunction.
    Neurology. 2020;94:1009-1010.
    >> Share

    May 2020
  175. YIN J, Reiman EM, Beach TG, Serrano GE, et al
    Effect of ApoE isoforms on mitochondria in Alzheimer disease.
    Neurology. 2020 May 26. pii: WNL.0000000000009582.
    >> Share

  176. MATTSSON-CARLGREN N, Leuzy A, Janelidze S, Palmqvist S, et al
    The implications of different approaches to define AT(N) in Alzheimer disease.
    Neurology. 2020 May 12. pii: WNL.0000000000009485.
    >> Share

  177. JACOBS HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, et al
    The presubiculum links incipient amyloid and tau pathology to memory function in older persons.
    Neurology. 2020;94:e1916-e1928.
    >> Share

  178. BERNATH MM, Bhattacharyya S, Nho K, Barupal DK, et al
    Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers.
    Neurology. 2020 May 1. pii: WNL.0000000000009436.
    >> Share

    April 2020
  179. SMIRNOV DS, Galasko D, Edland SD, Filoteo JV, et al
    Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies.
    Neurology. 2020 Apr 24. pii: WNL.0000000000009434.
    >> Share

  180. SARYCHEVA T, Lavikainen P, Taipale H, Tiihonen J, et al
    Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009435.
    >> Share

  181. VILAPLANA E, Rodriguez-Vieitez E, Ferreira D, Montal V, et al
    Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease.
    Neurology. 2020 Apr 14. pii: WNL.0000000000009405.
    >> Share

  182. ARENAZA-URQUIJO EM, Przybelski SA, Machulda MM, Knopman DS, et al
    Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults.
    Neurology. 2020;94:e1571-e1579.
    >> Share

    March 2020
  183. BREITNER J, Meyer PF
    Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:594.
    >> Share

  184. ASHFORD JW
    Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:593-594.
    >> Share

  185. GANESH A, Galetta S
    Editors' note: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:593.
    >> Share

  186. DOECKE JD, Perez-Grijalba V, Fandos N, Fowler C, et al
    Total Abeta42/Abeta40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.
    Neurology. 2020 Mar 16. pii: WNL.0000000000009240.
    >> Share

  187. TERADA T, Obi T, Bunai T, Matsudaira T, et al
    In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
    Neurology. 2020 Mar 5. pii: WNL.0000000000009249.
    >> Share

  188. SWERDLOW RH
    Mitochondria in Alzheimer brains: A PET project shows complex changes.
    Neurology. 2020 Mar 5. pii: WNL.0000000000009236.
    >> Share

    February 2020
  189. FERREIRA D, Nordberg A, Westman E
    Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.
    Neurology. 2020 Feb 11. pii: WNL.0000000000009058.
    >> Share

  190. HAAKSMA ML, Eriksdotter M, Rizzuto D, Leoutsakos JS, et al
    Survival time tool to guide care planning in people with dementia.
    Neurology. 2020;94:e538-e548.
    >> Share

  191. MCSWEENEY M, Pichet Binette A, Meyer PF, Gonneaud J, et al
    Intermediate flortaucipir uptake is associated with Abeta-PET and CSF-tau in asymptomatic adults.
    Neurology. 2020 Feb 3. pii: WNL.0000000000008905.
    >> Share

    January 2020
  192. RESENDE EPF, Nolan AL, Petersen C, Ehrenberg AJ, et al
    Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes: Astrocytic tau, cognitive function, and Alzheimer disease.
    Neurology. 2020 Jan 30. pii: WNL.0000000000008937.
    >> Share

  193. HOLLAND TM, Agarwal P, Wang Y, Leurgans SE, et al
    Dietary flavonols and risk of Alzheimer dementia.
    Neurology. 2020 Jan 29. pii: WNL.0000000000008981.
    >> Share

  194. MARTERSTECK A, Sridhar J, Rader B, Coventry C, et al
    Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease.
    Neurology. 2020 Jan 22. pii: WNL.0000000000008960.
    >> Share

  195. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Author response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:144-145.
    >> Share

  196. NELSON P
    Reader response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143-144.
    >> Share

  197. SIEGLER JE 3RD, Galetta S
    Editors' note: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143.
    >> Share

  198. WAZIRY R, Chibnik LB, Bos D, Ikram MK, et al
    Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature.
    Neurology. 2020 Jan 16. pii: WNL.0000000000008924.
    >> Share

  199. YU L, Boyle PA, Dawe RJ, Bennett DA, et al
    Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons.
    Neurology. 2020;94:e142-e152.
    >> Share

    December 2019
  200. SOLDAN A, Pettigrew C, Zhu Y, Wang MC, et al
    White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Neurology. 2019 Dec 30. pii: WNL.0000000000008864.
    >> Share

  201. CAVEDO E, Lista S, Houot M, Vergallo A, et al
    Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
    Neurology. 2019 Dec 4. pii: WNL.0000000000008696.
    >> Share

    November 2019
  202. HONDA T, Ohara T, Shinohara M, Hata J, et al
    Serum elaidic acid concentration and risk of dementia: The Hisayama Study.
    Neurology. 2019;93:e2053-e2064.
    >> Share

  203. GRAFF-RADFORD J, Gunter JL, Jones DT, Przybelski SA, et al
    Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008616.
    >> Share

  204. WEINTRAUB S, Teylan M, Rader B, Chan KCG, et al
    APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort.
    Neurology. 2019 Nov 8. pii: WNL.0000000000008666.
    >> Share

    October 2019
  205. NETH BJ
    Right brain: Art and the restoration of identity in dementia.
    Neurology. 2019;93:719-721.
    >> Share

  206. CHONG JSX, Jang H, Kim HJ, Ng KK, et al
    Amyloid and cerebrovascular burden divergently influence brain functional network changes over time.
    Neurology. 2019;93:e1514-e1525.
    >> Share

  207. SCHNEIDER LS, Geffen Y, Rabinowitz J, Thomas RG, et al
    Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial.
    Neurology. 2019;93:e1474-e1484.
    >> Share

  208. MIRZA SS, Saeed U, Knight J, Ramirez J, et al
    APOE varepsilon4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia.
    Neurology. 2019 Oct 1. pii: WNL.0000000000008377.
    >> Share

    July 2019
  209. WOLTERS FJ, Zonneveld HI, Licher S, Cremers LGM, et al
    Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI.
    Neurology. 2019 Jul 31. pii: WNL.0000000000008003.
    >> Share

  210. BISCHOF GN, Jacobs HIL
    Subthreshold amyloid and its biological and clinical meaning: Long way ahead.
    Neurology. 2019;93:72-79.
    >> Share

    June 2019
  211. TAGHDIRI F, Multani N, Tarazi A, Naeimi SA, et al
    Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions.
    Neurology. 2019;92:e2717-e2726.
    >> Share

    April 2019
  212. SOLDAN A, Pettigrew C, Fagan AM, Schindler SE, et al
    ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes.
    Neurology. 2019;92:e1567-e1579.
    >> Share

    March 2019
  213. SATHYAN S, Wang T, Ayers E, Verghese J, et al
    Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study.
    Neurology. 2019;92:e1427-e1434.
    >> Share

  214. PRESSMAN PS, Gola K, Shdo SM, Miller BL, et al
    Relative preservation of facial expression recognition in posterior cortical atrophy.
    Neurology. 2019;92:e1064-e1071.
    >> Share

    February 2019
  215. WILSON RS, Yang J, Yu L, Leurgans SE, et al
    Postmortem neurodegenerative markers and trajectories of decline in cognitive systems.
    Neurology. 2019;92:e831-e840.
    >> Share

  216. MORAN C, Beare R, Wang W, Callisaya M, et al
    Type 2 diabetes mellitus, brain atrophy, and cognitive decline.
    Neurology. 2019;92:e823-e830.
    >> Share

  217. BUCHMAN AS, Yu L, Wilson RS, Lim A, et al
    Physical activity, common brain pathologies, and cognition in community-dwelling older adults.
    Neurology. 2019;92:e811-e822.
    >> Share

    January 2019
  218. WHITWELL JL, Martin PR, Duffy JR, Clark HM, et al
    The influence of beta-amyloid on [(18)F]AV-1451 in semantic variant of primary progressive aphasia.
    Neurology. 2019 Jan 11. pii: WNL.0000000000006913.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016